...
首页> 外文期刊>Pharmaceutical Nanotechnology >Computer Optimization of Stealth Biodegradable Polymeric Dual-loaded Nanoparticles for Cancer Therapy Using Central Composite Face-centered Design
【24h】

Computer Optimization of Stealth Biodegradable Polymeric Dual-loaded Nanoparticles for Cancer Therapy Using Central Composite Face-centered Design

机译:中央复合脸部设计的癌症治疗中隐性可生物降解聚合物双负荷纳米粒子的计算机优化

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Combination chemotherapy capable of overcoming cancer drugresistance can be facilitated by nanotechnology.Objective: Synthesis, characterization, statistical experimental design, analysis and optimizationof stealth pH-sensitive polymeric nanoparticles suitable as a platform for simultaneousdelivery of paclitaxel and 17-AAG in breast cancer therapy were investigated.Methods: An acetal crosslinker and a poly(?)caprolactone macromonomer were synthesizedand characterized. The statistical experimental design used was the response surfacemethod (RSM). We used the central composite face-centered design (CCF) in three independentfactors and seventeen runs. Nanoparticles were fabricated by dispersion polymerizationtechniques. Response variables evaluated were: particle size, drug loading, encapsulationefficiency, and in vitro availability.Results: Scanning electron micrographs showed the formation of spherical nanoparticles.Computer software was used for the analysis of variance with a 95% confidence level andQ2 (goodness of prediction) to select an appropriate model for each of the responsevariables. Each term in each of the models was tested for the significance of the regressioncoefficients. The computer software optimizer was used for optimization to select factorcombination to minimize particle size, time (h) for maximum release of paclitaxel and17-AAG, to maximize paclitaxel and 17-AAG loading efficiency and to maximizepaclitaxel and 17-AAG encapsulation efficiency.Conclusion: The optimization was successful, as shown by the validation data which liewithin the confidence intervals of predicted values of the response variables. The selectedfactor combination is suitable for the in vivo evaluation of the nanoparticles loaded withpaclitaxel and 17-AAG.
机译:背景:能够通过纳米技术促进能够克服癌症德鲁格病毒的组合化疗。目的:合成,表征,统计实验设计,分析和优化,其适用于紫杉醇患者紫杉醇和17-AAG的同时发放的平台。被研究。方法:缩醛交联剂和聚(α)己内酯大分子单体是合成的,其特征在于。使用的统计实验设计是响应SurfaceMethod(RSM)。我们在三个独立性物质和17次运行中使用了中央复合面中心设计(CCF)。纳米颗粒通过分散聚合技术制备。评估的响应变量是:粒度,药物载荷,包封效率和体外可用性。结果:扫描电子显微照片显示球形纳米颗粒的形成。组算机软件用于分析与95%置信水平和Q2的差异(预测的良好)为每个responsevariables选择适当的模型。测试每个模型中的每个术语对于回归截止值的重要性。计算机软件优化器用于优化以选择因子组成,以最大限度地减少粒度,时间(H),以最大释放紫杉醇和17-AAG,以最大化PACLITAXEL和17-AAG负载效率和最大化的十六段加载效率和17℃封装效率。结论:优化是成功的,如验证数据所示,验证数据所示,其中Liewithin响应变量的预测值的置信区间。选择的物质组合适用于纳米颗粒的纳米颗粒的体内评价,并达到过paclitaxel和17-aag。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号